Today: 11 June 2026
SoFi (SOFI) stock slides nearly 4% as JPMorgan stake filing lands — what traders watch next
5 February 2026
1 min read

SoFi (SOFI) stock slides nearly 4% as JPMorgan stake filing lands — what traders watch next

New York, February 5, 2026, 12:50 (EST) — Regular session

  • SoFi shares dropped 3.7% to $19.98 during mid-session trading, having earlier dipped to $19.20.
  • A JPMorgan filing revealed its SoFi stake had dipped under 5%, slipping below the threshold that mandates big-holder disclosures.
  • JPMorgan analyst Reginald Smith upgraded the stock this week, even as other fintech peers took a hit.

Shares of SoFi Technologies dropped 3.7% to $19.98 on Thursday, lagging a soft U.S. market as investors reacted to a new JPMorgan ownership filing. The stock touched an intraday low of $19.20.

SoFi has swung back into being a sentiment-driven stock. It can jump sharply on shifts in institutional positioning, analyst upgrades or downgrades, and interest rate news—often without any fresh updates from the company itself.

This week showed a classic tug-of-war: JPMorgan’s own team grew more upbeat on the stock, yet a regulatory filing revealed its stake had dropped below the disclosure threshold. Investors often combine those signals, whether that’s justified or not.

JPMorgan Chase & Co. disclosed in a Schedule 13G/A filed Wednesday that it owns 47,207,186 shares of SoFi, representing 3.7% of the company’s class as of Jan. 30. This marks a decline from a previous Schedule 13G in January, which showed a 5.1% stake as of Dec. 31. (The “/A” indicates this is an amended filing.) Securities and Exchange Commission

JPMorgan’s Reginald Smith raised SoFi to “Overweight” from “Neutral,” keeping the price target steady at $31. He said the recent dip in shares provided “the entry point” they’d been waiting for, highlighting the company’s “undeniable” momentum. TipRanks

Thursday saw a wider sell-off in stocks. The S&P 500 ETF SPY dropped 0.7%, the Nasdaq-100 proxy QQQ lost 0.6%, and the financial sector ETF XLF edged down roughly 0.7%.

Other high-beta fintech stocks slipped as well. Upstart declined roughly 5.2%, Robinhood slid about 5.3%, while LendingClub and Affirm dropped between 2% and 3%.

San Francisco’s SoFi operates at the intersection of consumer lending and digital banking, while also running a tech platform that provides infrastructure to other financial firms. This blend makes it vulnerable to changes in the credit cycle and swings in risk appetite.

One unresolved issue: the filings don’t clarify why position sizes shift, and a 13G isn’t an activist flag. Yet traders keep an eye on whether other big holders file similar disclosures, particularly when the stock is already in decline.

Risks cut both ways now. Should credit concerns spike or investors demand a reset on the sector’s growth multiples, SoFi could slide further despite upbeat analyst commentary. On the flip side, a drop in rates coupled with a rebound in risk appetite might push it higher.

Traders are now focused on the U.S. data calendar for clues on interest rates. The Bureau of Labor Statistics has scheduled the January Employment Situation report for Feb. 11 at 8:30 a.m. Eastern. This follows adjustments to release dates due to a government services lapse.

Stock Market Today

  • Kymera Therapeutics Stock Rebounds Amid Valuation Debate at $78.23
    June 10, 2026, 10:45 PM EDT. Kymera Therapeutics (KYMR) shares rose 6.9% last week after a 7% decline over the past month, trading at $78.23 with a 33.9% undervaluation consensus. Analyst fair value estimates average $118.27, implying substantial upside based on planned annual IND (Investigational New Drug) filings and a cash runway into mid-2027 supporting R&D. The biotech's long-term shareholders have seen a 1-year total return of 61.7% and 3-year return above 200%. Risks remain from potential R&D setbacks and partner dependency, notably on Sanofi, tempering the growth outlook. Investors are advised to closely evaluate positive catalysts alongside the execution challenges in this AI-driven drug development sector.

Latest articles

Tech stocks slide after hours, Oracle’s AI spending draws focus

Tech stocks slide after hours, Oracle’s AI spending draws focus

11 June 2026
Semiconductor stocks plunged 3.6%, dragging the S&P 500 technology sector into correction territory—down 11% from its June 2 record—as investors punished AI-linked companies like Oracle and Super Micro Computer for heavy spending and capital raises, signaling a shift in risk appetite amid rising inflation and escalating U.S.-Iran tensions.
Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

11 June 2026
Murphy USA soared 10.04% to $612.16 as investors seized on Casey’s General Stores’ stronger-than-expected fuel margins, spotlighting sector-wide pump profitability; with Murphy’s own first-quarter fuel contribution up 40.6% and margins at 35.0 cents per gallon, the stock’s jump reflects bets that high margins will persist, though volatility in fuel prices remains a key risk.
Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

11 June 2026
Sky Quarry soared 22.44% to $1.91 on record volume, then jumped to $2.38 after hours, as investors bet on a June refinery restart after repairs and a feedstock shortage crushed Q1 revenue to $383; with just $66,828 in cash and “substantial doubt” about its ability to continue, the stock’s fate hinges on hitting its June production target.
Applied Materials (AMAT) stock snaps back near $300 as Alphabet AI spend stirs chip-equipment trade
Previous Story

Applied Materials (AMAT) stock snaps back near $300 as Alphabet AI spend stirs chip-equipment trade

NIO stock jumps after profit alert flags first quarterly operating profit — what investors watch next
Next Story

NIO stock jumps after profit alert flags first quarterly operating profit — what investors watch next

Go toTop